Variants in GLP1R (rs6923761), MC4R (rs17782313), and FTO (rs9939609) influence gastric emptying rate, hunger signaling, and GI tolerance
Survodutide for weight loss Survodutide (BI 456906), a novel dual GLP-1 and glucagon receptor agonist, demonstrated weight loss of up to 18.7% over 46 weeks in overweight or obese people participating in its phase 2, randomised, placebo-controlled, dose-finding trial presented at the Sessions
All the companies listed below are top priority for all factors
Increase your fibre intake
#GutHealth #BrainHealth #NervousSystem #Cortisol #Inflammation To view or add a comment, sign in Did you know that one concussion may recover fully, but repeated head injuries can increase the risk of long term neurodegeneration
The following are 11 vitamin C benefits